Mutator phenotype in Msh2-deficient murine embryonic fibroblasts

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3765-3771

  Reitmair, Armin H ^a   Risley, Robert ^b   Bristow, Robert G ^a   Wilson, Teresa ^c   Ganesh, Anil ^b   Jang, Anne ^a   Peacock, James ^d   Benchimol, Samuel ^d   Hill, Richard P ^a   Mak, Tak W ^a   Fishel, Richard ^c   Meuth, Mark ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MICROSATELLITE DNA; TIOGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASE MISPAIRING; CARCINOGENESIS; CELL IMMORTALIZATION; COLON CANCER; CYTOTOXICITY; DNA DAMAGE; DRUG SENSITIVITY; EMBRYO; FIBROBLAST; GENETIC TRANSFECTION; HETEROZYGOSITY LOSS; MOUSE; MUTATION RATE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE; CINNAMATES; CISPLATIN; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE; FIBROBLASTS; GENES, P53; GENES, RAS; HUMANS; HYGROMYCIN B; MICE; MICE, INBRED C57BL; MICROSATELLITE REPEATS; MUTAGENESIS; MUTS HOMOLOG 2 PROTEIN; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RADIATION-SENSITIZING AGENTS; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 14444268973     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. de la Chapelle, A., and Peltomäki, P. Genetics of hereditary colon cancer. Annu. Rev. Genet., 29: 329-348, 1995.
2. Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutation gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038, 1993.
3. Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyströsm-Lahti, M., Guan, X-Y., Zhang, J., Meltzer, P. S., Yu, J-W., Kao, F-T., Chen, D. J., Cerosaletti, K. M., Fournier, R. E. K., Todd, S., Lewis, T., Leach, R. J., Naylor, S. L., Weissenbach, J., Mecklin, J-P., Järvinen, H., Petersen, G. M., Hamilton, S. R., Green, J., Jass, J., Watson, P., Lynch, H. T., Trent, J. M., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.
4. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R., and Liskay, R. M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (Lond.), 368: 258-261, 1994.
5. Papadopoulos, N., Nicolaides, N. C., Wei, Y-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomäki, P., Mecklin, J-P., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutation of a mutL homolog in hereditary colon cancer. Science (Washington DC), 263: 1625-1629, 1994.
6. Nicolaides, N. C., Papadopoulos, N., Liu, B., Wei, Y-F., Carter, K. C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Dunlops, M. G., Hamilton, S., Petersen, G. M., de la Chapelle, A., Vogelstein, B., and Kinzler, K. W. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (Lond.), 371: 75-80, 1994.
7. Parsons, R., Li, G-M., Longley, M. J., Fang, W-H., Papadopoulos, N., Jen, J., de la Chapelle, A., Kinzler, K. W., Vogelstein, B., and Modrich, P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell, 75: 1227-1236, 1993.
8. Boyer, J. C., Umar, A., Risinger, J. I., Lipford, J. R., Kane, M., Yin, S., Barrett, J. C., Kolodner, R. D., and Kunkel, T. A. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res., 55: 6063-6070, 1995.
9. Drummond, J. T., Li, G-M., Longley, M. J., and Modrich, P. Isolation of a hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science (Washington DC), 268: 1909-1911, 1995.
10. Palombo, F., Gallinari, P., Iaccarino, I., Lettieri, T., Hughes, M., D'Arrigo, A., Truong, O., Hsuan, J. J., and Jiricny, J. GTBP, a 160 kilodalton protein essential for mismatch binding activity in human cells. Science (Washington DC), 268: 1912-1914, 1995.
11. Acharya, S., Wilson, T., Gradia, S., Kane, M. F., Guerette, S., Marsischky, G. T., Kolodner, R., and Fishel, R. hMSH2 forms specific mispair binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA, 93: 13629-13634, 1996.
12. Papadopoulos, N., Nicolaides, N. C., Liu, B., Parsons, R., Lengauer, C., Palombo, F., D'Arrigo, A., Markowitz, S., Willson, J. K. V., Kinzler, K. W., Jiricny, J., and Vogelstein, B. Mutations of GTBP in genetically unstable cells. Science (Washington DC), 268: 1915-1917, 1995.
13. Risinger, J. I., Umar, A., Boyd, J., Berchuck, A., Kunkel, T. A., and Barret, J. C. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat. Genet., 14: 102-105, 1996.
14. Malkhosyan, S., Rampino, N., Yamamoto, H., and Perucho, M. Frameshift mutator mutations. Nature (Lond.), 382: 499-500, 1996.
15. Shibata, D., Peinado, M. A., Ionov, Y., Malkhosyan, S., and Perucho, M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat. Genet., 6: 273-281, 1994.
16. Bhattacharyya, N. P., Skandalis, A., Ganesh, A., Groden, J., and Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 91: 6319-6323, 1994.
17. Kat, A., Thilly, W. G., Fang, W-H., Longley, M. J., Li, G-M., and Modrich, P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA, 90: 6424-6428, 1993.
18. Eshleman, J. R., Lang, E. Z., Bowerfind, G. K., Parsons, R., Vogelstein, B., Willson, J. K. V., Veigl, M. L., Sedwick, W. D., and Markowitz, S. D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene, 10: 33-37, 1995.
19. Phear, G., Bhattacharyya, N. P., and Meuth, M. Loss of heterozygosity and base substitution at the APRT locus in mismatch repair-proficient and -deficient colorectal carcinoma cell lines. Mol. Cell. Biol., 16: 6516-6523, 1996.
20. Anthony, D. A., McIlwrath, A., Gallagher, W., Edlin, A., and Brown, R. Microsatellite instability, apoptosis and loss of p53 function in drug-resistant tumor cells. Cancer Res., 56: 1374-1381, 1996.
21. Aebi, S., Kurdi-Haidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., Christen, R. D., Bolund, C. R., Koi, M., Fishel, R., and Howell, S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56: 3087-3090, 1996.
22. Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehme, A., Christen, R. D., and Howell, S. B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res., 56: 4881-4886, 1996.
23. Mello, J. A., Acharya, S., Fishel, R., and Essigman, J. M. The mismatch repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol., 3: 579-589, 1996.
24. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA, 93: 6443-6447, 1996.
25. Karran, P., and Bignami, M. DNA damaged tolerance, mismatch repair and genome instability. BioEssays. 16: 833-839, 1994.
26. Mellon, I., Rajpal, D. K., Koi, M., Boland, C. R., and Champe, G. N. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science (Washington DC), 272: 557-560, 1996.
27. da Costa, L. T., Liu, B., El-Deiry, W. S., Hamilton, S. R., Kinzler, K. W., Vogelstein, B., Markowitz, S., Wilson, J. K. V., de la Chapelle, A., Downey, K. M., and So, A. G. Polymerase δ variants in RER colorectal tumours. Nat. Genet., 9: 10-11, 1995.
28. Reitmair, A. H., Schmits, R., Ewel, A., Bapat, B., Redston, M., Waterhouse, P., Mittrucker, H-W., Wakeham, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Balhausen, W. G., Fishel, R., and Mak, T. W. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet., 11: 64-70, 1995.
29. de Wind, N., Dekker, M., Berns, A., Radman, M., and te Riele, H. Inactivation of the mouse MSH2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell, 82: 321-330, 1995.
30. Baker, S. M., Bronner, C. E., Zhang, L., Plug, A. W., Robatzek, M., Warren, G., Elliott, E. A., Yu, J., Ashley, T., Arnheim, N., Flavell, R. A., and Liskay, R. M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell, 82: 309-319, 1995.
31. Baker, S. M., Plug, A. W., Prolla, T. A., Bronner, C. E., Harris, A. C., Yao, X., Christie, D-M., Monell, C., Arnheim, N., Bradley, A., Ashley, T., and Liskay, R. M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet., 13: 336-342, 1996.
32. Edelman, W., Cohen, P. E., Kane, M., Lau, K., Morrow, B., Bennett, S., Umar, A., Kunkel, T., Cattoretti, G., Chaganti, R., Pollard, J. W., Kolodner, R. D., and Kucherlapati, R. Meiotic pachytene arrest in MLH-1-deficieni mice. Cell, 85: 1125-1134, 1996.
33. Reitmair, A. H., Redston, M., Cai, J. C., Chuang, T. C. Y., Bjerknes, M., Cheng, H., Hay, K., Gallinger, S., Bapat, B., and Mak, T. W. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res., 56: 3842-3849, 1996.
34. Dunlop, M. G., Farrington, S. M., Carothers, A. D., Wyllie, A. H., Sharp, L., Liu, B., Kinzler, K. W., and Vogelstein, B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum. Mol. Genet., 6: 105-110: 1997.
35. Rovinski, B., and Benchimol, S. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene, 2: 445-452, 1988.
36. Storey, A., Pim, D., Murray, A., Osborn, K., Banks, L., and Crawford, L. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J., 7: 1815-1820, 1988.
37. Shih, C., and Weinberg, R. A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell, 29: 161-169, 1982.
38. Bernard, H. U., Kraemmer, G., and Roewekamp, W. G. Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res., 158: 237-243, 1985.
39. Munroe, D. G., Peacock, J. W., and Benchimol, S. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol., 10: 3307-3313, 1990.
40. Wilson, T. M., Ewel, A., Duguid, J. R., Eble, J. N., Lescoe, M. K., Fishel, R., and Kelley, M. R. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res., 55: 5146-5150, 1995.
41. Fishel, R., Ewel, A., Lee, S., Lescoe, M. K., and Griffith, J. Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science (Washington DC), 266: 1403-1405, 1994.
42. Siminovitch, L. On the nature of hereditable variation in cultured somatic cells. Cell, 7: 1-11, 1976.
43. 2 cell cycle checkpoint. Cancer Res., 55: 3721-3725, 1995.
44. Ford, J. M., and Hanawalt, P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA, 92: 8876-8880, 1995.
45. Lazar, V., Grandjouan, S., Bognel, C. Couturier, D., Rougier, P., Bellet, D., and Bressac-de Paillerets, B. Accumulation of multiple mutations in tumor suppressor genes during tumorigenesis in HNPCC patients. Hum. Mol. Genet., 3: 2257-2260, 1994.
46. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 208: 1336-1338, 1995.
47. Huang, J., Papadopoulos, N., McKinley, A. J., Farrington, S. M., Curtis, L. J., Wyllie, A. H., Zheng, S., Willson, J. K. V., Markowitz, S. D., Morin, P., Kinzler, K. W., Vogelstein, B., and Dunlop, M. G. APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. USA, 93: 9049-9054, 1996.
48. Varlet, I., Pallard, C., Radman, M., Moreau, J., and de Wind, N. Cloning and expression of the Xenopus and mouse Msh2 DNA mismatch repair genes. Nucleic Acids Res., 22: 5723-5728, 1994.
49. Leach, F. S., Polyak, K., Burrell, M., Johnson, K. A., Hill, D., Dunlop, M. G., Wyllie, A. H., de la Chapelle, A., Hamilton, S. R., Kinzler, K. W., and Vogelstein, B. Expression of the human mismatch repair genes in normal and neoplastic tissues. Cancer Res., 56: 235-240, 1996.